These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 37843374)
41. A novel adeno-associated virus capsid with enhanced neurotropism corrects a lysosomal transmembrane enzyme deficiency. Tordo J; O'Leary C; Antunes ASLM; Palomar N; Aldrin-Kirk P; Basche M; Bennett A; D'Souza Z; Gleitz H; Godwin A; Holley RJ; Parker H; Liao AY; Rouse P; Youshani AS; Dridi L; Martins C; Levade T; Stacey KB; Davis DM; Dyer A; Clément N; Björklund T; Ali RR; Agbandje-McKenna M; Rahim AA; Pshezhetsky A; Waddington SN; Linden RM; Bigger BW; Henckaerts E Brain; 2018 Jul; 141(7):2014-2031. PubMed ID: 29788236 [TBL] [Abstract][Full Text] [Related]
42. Tracking Adeno-Associated Virus Capsid Evolution by High-Throughput Sequencing. de Alencastro G; Pekrun K; Valdmanis P; Tiffany M; Xu J; Kay MA Hum Gene Ther; 2020 May; 31(9-10):553-564. PubMed ID: 32024384 [TBL] [Abstract][Full Text] [Related]
43. Characterization of Adeno-Associated Viral Vector-Mediated Human Factor VIII Gene Therapy in Hemophilia A Mice. Greig JA; Wang Q; Reicherter AL; Chen SJ; Hanlon AL; Tipper CH; Clark KR; Wadsworth S; Wang L; Wilson JM Hum Gene Ther; 2017 May; 28(5):392-402. PubMed ID: 28056565 [TBL] [Abstract][Full Text] [Related]
44. Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants. Rapti K; Maiakovska O; Becker J; Szumska J; Zayas M; Bubeck F; Liu J; Gerstmann E; Krämer C; Wiedtke E; Grimm D J Vis Exp; 2022 Oct; (188):. PubMed ID: 36342179 [TBL] [Abstract][Full Text] [Related]
45. Employing a gain-of-function factor IX variant R338L to advance the efficacy and safety of hemophilia B human gene therapy: preclinical evaluation supporting an ongoing adeno-associated virus clinical trial. Monahan PE; Sun J; Gui T; Hu G; Hannah WB; Wichlan DG; Wu Z; Grieger JC; Li C; Suwanmanee T; Stafford DW; Booth CJ; Samulski JJ; Kafri T; McPhee SW; Samulski RJ Hum Gene Ther; 2015 Feb; 26(2):69-81. PubMed ID: 25419787 [TBL] [Abstract][Full Text] [Related]
46. Structural and antigenic characterization of the avian adeno-associated virus capsid. Hsi J; Mietzsch M; Chipman P; Afione S; Zeher A; Huang R; Chiorini J; McKenna R J Virol; 2023 Oct; 97(10):e0078023. PubMed ID: 37702486 [TBL] [Abstract][Full Text] [Related]
59. Optimization of AAV vectors to target persistent viral reservoirs. Colón-Thillet R; Jerome KR; Stone D Virol J; 2021 Apr; 18(1):85. PubMed ID: 33892762 [TBL] [Abstract][Full Text] [Related]
60. Gene therapy for the CNS using AAVs: The impact of systemic delivery by AAV9. Saraiva J; Nobre RJ; Pereira de Almeida L J Control Release; 2016 Nov; 241():94-109. PubMed ID: 27637390 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]